News | October 11, 2024
Privi Speciality Chemicals gets USFDA certificate for camphor product
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Total Income during Q3 FY25 stood at Rs. 527.37 crore as compared to Rs. 528.77 crore in Q3 FY24
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Total Income in Q2 FY25 stood at Rs. 532.18 crore
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Subscribe To Our Newsletter & Stay Updated
